Pacific Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Pacific Biosciences's estimated annual revenue is currently $121.6M per year.
- Pacific Biosciences's estimated revenue per employee is $142,758
- Pacific Biosciences's total funding is $1.3B.
- Pacific Biosciences's current valuation is $2.7B. (January 2022)
Employee Data
- Pacific Biosciences has 852 Employees.
- Pacific Biosciences grew their employee count by 9% last year.
Pacific Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & President | Reveal Email/Phone |
2 | VP, Software | Reveal Email/Phone |
3 | VP and General Manager | Reveal Email/Phone |
4 | VP Engineering Development | Reveal Email/Phone |
5 | VP, Chips Development | Reveal Email/Phone |
6 | VP Customer Experience | Reveal Email/Phone |
7 | VP Intellectual Property | Reveal Email/Phone |
8 | VP Development | Reveal Email/Phone |
9 | VP, Software | Reveal Email/Phone |
10 | VP, Intellectual Property | Reveal Email/Phone |
Pacific Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12M | 362 | 6% | $208.1M | N/A |
#2 | $434.8M | 1865 | -14% | $2B | $2.7B |
#3 | $4280M | 11139 | -4% | $28M | $63.3B |
What Is Pacific Biosciences?
Pacific Biosciences (PacBio), headquartered in Menlo Park, CA, is a startup biotechnology company developing a transformative Single Molecule Real Time (SMRT™) DNA sequencing platform. PacBio’s goal is to commercialize SMRT DNA sequencing technology, eventually enabling sequencing of individual genomes as part of routine medical care. The company is currently venture funded by Kleiner Perkins Caufield & Byers, Mohr Davidow Ventures, Alloy Ventures, Maverick Capital, and others.
keywords:N/A
$1.3B
Total Funding
852
Number of Employees
$121.6M
Revenue (est)
9%
Employee Growth %
$2.7B
Valuation
N/A
Accelerator
Pacific Biosciences News
NEW YORK Researchers at Children's Mercy Kansas City are among the first to try out a new capability from Pacific Biosciences: the ability...
NEW YORK Pacific Biosciences said on Monday that it is collaborating with Corteva Agriscience to develop custom workflows for plant, pest,...
Pacific Biosciences Hit By Sentiment, But The Future Of Long-Read Sequencing Is Strong · Summary · Another Step Toward The Ag Opportunity · Expect...
Pacific Biosciences of California Inc. (NSDQ:PACB) won a favorable decision from the U.S. Patent Office over a competitor. The Menlo Park, Calif.-based company began a "patent interference" process against Life Technologies Corp. (NSDQ:LIFE) in March 2009 regarding patent claims by both compani ...
Pacific Biosciences, a Menlo Park, California-based company developing a technology platform for real-time detection of biological events at single molecule resolution, has completed a $109m Series F financing round. The round also includes a previously announced $50m strategic investment by Ge ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $278.3M | 984 | -31% | N/A |
#2 | $75M | 988 | 0% | N/A |
#3 | $300M | 1181 | 9% | $2B |
#4 | $262.5M | 1293 | 54% | N/A |
#5 | $226.3M | 1347 | N/A | N/A |